Literature DB >> 33639056

A Peer-Based Strategy to Overcome HPV Vaccination Inequities in Rural Communities: A Physical Distancing-Compliant Approach.

Christine Finley1, Matthew J Dugan2, Jan Kirk Carney2, Wendy Sue Davis3, Thomas V Delaney2, Victoria C Hart2, Breena W Holmes4, Gary S Stein5, Robin Katrick6, Holly Morehouse6, Bernard Cole2, Leslie S Bradford7, Maureen B Boardman8, Heidi Considine9, Nancy C Kaplan9, Merideth Plumpton1, Linda Schadler2, Jennifer J Smith2, Kate McAllister10.   

Abstract

The human papilloma virus (HPV) vaccine is the world's first proven and effective vaccine to prevent cancers in males and females when administered pre-exposure. Like most of the US, barely half of Vermont teens are up-to-date with the vaccination, with comparable deficits in New Hampshire and Maine. The rates for HPV vaccine initiation and completion are as low as 33% in rural New England. Consequently, there is a compelling responsibility to communicate its importance to unvaccinated teenagers before their risk for infection increases. Messaging in rural areas promoting HPV vaccination is compromised by community-based characteristics that include access to appropriate medical care, poor media coverage, parental and peer influence, and skepticism of science and medicine. Current strategies are predominantly passive access to literature and Internet-based information. Evidence indicates that performance-based messaging can clarify the importance of HPV vaccination to teenagers and their parents in rural areas. Increased HPV vaccination will significantly contribute to the prevention of a broadening spectrum of cancers. Reducing rurality-based inequities is a public health priority. Development of a performance-based peer-communication intervention can capture a window of opportunity to provide increasingly effective and sustained HPV protection. An effective approach can be partnering rural schools and regional health teams with a program that is nimble and scalable to respond to public health policies and practices compliant with COVID-19 pandemic-related modifications on physical distancing and interacting in the foreseeable future.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33639056      PMCID: PMC8128079          DOI: 10.1615/CritRevEukaryotGeneExpr.2021036945

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  6 in total

1.  Modeling and reinforcement to combat HIV: the MARCH approach to behavior change.

Authors:  C Galavotti; K A Pappas-DeLuca; A Lansky
Journal:  Am J Public Health       Date:  2001-10       Impact factor: 9.308

2.  East Los High: Transmedia Edutainment to Promote the Sexual and Reproductive Health of Young Latina/o Americans.

Authors:  Hua Wang; Arvind Singhal
Journal:  Am J Public Health       Date:  2016-04-14       Impact factor: 9.308

3.  Entertainment-education and HIV/AIDS prevention: a field experiment in Tanzania.

Authors:  P W Vaughan; E M Rogers; A Singhal; R M Swalehe
Journal:  J Health Commun       Date:  2000

Review 4.  Youth performing arts entertainment-education for HIV/AIDS prevention and health promotion: practice and research.

Authors:  Deborah Glik; Glen Nowak; Thomas Valente; Karena Sapsis; Chad Martin
Journal:  J Health Commun       Date:  2002 Jan-Feb

Review 5.  School-based drama interventions in health promotion for children and adolescents: systematic review.

Authors:  Katja Joronen; Sally H Rankin; Päivi Astedt-Kurki
Journal:  J Adv Nurs       Date:  2008-07       Impact factor: 3.187

6.  Effect of a web drama video series on HIV and other sexually transmitted infection testing among gay, bisexual and queer men: study protocol for a community-based, pragmatic randomised controlled trial in Singapore: the People Like Us (PLU) Evaluation Study.

Authors:  Rayner Kay Jin Tan; Wee Ling Koh; Daniel Le; Avin Tan; Adrian Tyler; Calvin Tan; Sumita Banerjee; Chen Seong Wong; Mee-Lian Wong; Martin Tze-Wei Chio; Mark I-Cheng Chen
Journal:  BMJ Open       Date:  2020-04-07       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.